NP Rank:
How Should Journalists Cover Basic Medical Research?
A quick article from Wired about medical journalism, discussing how to report research advancements when readers' attention and time are limited, and the chances of the reported-upon drug's success are slim:
Promising new drugs -- first their discovery, and then their performance at various trial stages, from animal to randomized humans -- are a standby of medical journalism.
But according to this analysis, the chances of a discovery succeeding only slightly better than those of salmon swimming an upstream gauntlet of hungry bears in order to mate. In this light, covering basic drug research seems almost misleading. (News Flash: Young Salmon Starts Migration! 'I just Know I'll Make It,' Says Hopeful Spawner). There are more immediately relevant stories on which journalists can expend their limited resources, and the public its attention.
Then there's the issue of why drug development takes so long. Is it hindered by excessive government regulation and the tremendous costs incurred by companies? If so, covering basic research is all the more merited. But if new drugs are slowed by outdated research paradigms, patent abuse and a blockbuster-driven industry model, covering them amounts to complicity.
Personally, I didn't realize that the average development time was 24 years. Now we don't feel quite so bad about not having a version of Highlight ready for Chrome!
Crowd Power
-
internal sabotage
Seattle, Washington, United States




Most RecentMost Recommended Comments (4)
at 09:36 on September 6th, 2008
jordan, I like this story. It's good stuff.
I think part of the problem is the general level of ignorance that people have about the science involved. I have friends who are agrochemists and pharmacists - to hear them talking 'shop' with colleagues, they might as well be speaking a foreign language - and I've got a fairly good general grasp of science!
All people want to hear is "science can cure this." Even when you go to the doctors, the last thing you want to hear is "change your diet, do some exercise and here's a list of side-effects." We just want the tablet that fixes the problem instantly.
I don't think the problem is limited to medical journalism. Look at any job that requires a masters degree to work in and journalists will have a hell of a job selling that to the general public, simply because we're not all engineers, surgeons, economists, diplomats, etc. For instance, how many people know what the Large Hadron Collider is actually for, compared to the millions that have seen a headline about it creating black-holes?
The bigger problem with reporting medicine is that it quite literally deals with life and death. It's almost easier to write a good headline for that sort of thing. Example: the jab that would immunise women against cervical cancer (HPV, the human papillomavirus vaccine). In the UK, the story isn't about protecting people from cancer, the story is about having to explain sex to 12/13-year-old girls. The real story is about how up-tight the British are and this noise is drowning-out the potential life-saving benefits of the drug. All because sex sells more newspapers than cancer.
If anything, the journalist's role should be to manage expectations. Yes, here's a great new drug, but it's only got a 10% success rate.
The problem there is that, when it comes to life and death, everybody forgets how statistics work and thinks that they'll be that 1-in-10.
at 13:33 on September 6th, 2008
jordan, I like this story. It's good stuff.
at 22:19 on September 6th, 2008
jordan, I like this story. It's good stuff.
at 22:22 on September 6th, 2008
I tried to give you a "good stuff" flag, because this is an interesting article. But the computer would not cooperate. Thanks for this article, Jordan.
Oh, I see it did show up. Good deal!
Mary